0000899243-22-031659.txt : 20220922
0000899243-22-031659.hdr.sgml : 20220922
20220922073103
ACCESSION NUMBER: 0000899243-22-031659
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220920
FILED AS OF DATE: 20220922
DATE AS OF CHANGE: 20220922
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pelizzon David R
CENTRAL INDEX KEY: 0001719217
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38242
FILM NUMBER: 221257847
MAIL ADDRESS:
STREET 1: 2850 FRONTIER DR
CITY: WARSAW
STATE: IN
ZIP: 46582
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ORTHOPEDIATRICS CORP
CENTRAL INDEX KEY: 0001425450
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 261761833
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2850 FRONTIER DRIVE
CITY: WARSAW
STATE: IN
ZIP: 46582
BUSINESS PHONE: 574-268-6379
MAIL ADDRESS:
STREET 1: 2850 FRONTIER DRIVE
CITY: WARSAW
STATE: IN
ZIP: 46582
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-09-20
0
0001425450
ORTHOPEDIATRICS CORP
KIDS
0001719217
Pelizzon David R
C/O SQUADRON CAPITAL LLC
18 HARTFORD AVE., PO BOX 223
GRANBY
CT
06035
1
0
1
0
Common Stock
2022-09-20
4
X
0
1525000
0.0003
A
6901764
I
See footnote
Common Stock
24816
D
Warrants (right to buy)
0.0003
2022-09-20
4
X
0
1525000
0.00
A
Common Stock
1525000
0
I
See footnote
These securities are held directly by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these securities. The reporting person expressly disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. The inclusion of these securities in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.
Squadron beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants could not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. On September 19, 2022, the waiting period under the HSR Act expired. Once the warrants became exercisable, Squadron Capital LLC was obligated to exercise them within five (5) business days.
/s/ David R. Pelizzon
2022-09-22